|
|
| (39 intermediate revisions by 8 users not shown) |
| Line 1: |
Line 1: |
| '''For patient information click [[Hyperlipidemia (patient information)|here]]'''
| | #Redirect [[Hyperlipoproteinemia]] |
| {{DiseaseDisorder infobox |
| |
| Name = Hyperlipidemia |
| |
| ICD10 = {{ICD10|E|78||e|78}} |
| |
| ICD9 = {{ICD9|272.0}}-{{ICD9|272.4}} |
| |
| DiseasesDB = 6255|
| |
| }}
| |
| | |
| {{Hyperlipidemia}}
| |
| | |
| {{CMG}}
| |
| | |
| ==[[Hyperlipidemia overview | Overview]]==
| |
| | |
| ==[[Hyperlipidemia risk factors | Risk factors]]==
| |
| | |
| ==[[Hyperlipidemia screening | Screening]]==
| |
| | |
| [[Hyperlipidemia primary prevention | Target population]] | [[Hyperlipidemia screening tests | Screening tests]] | [[Hyperlipidemia screening frequency | Screening frequency]]
| |
| | |
| ==[[Hyperlipidemia causes | Causes]]==
| |
| | |
| ==[[Hyperlipidemia classification | Classification]]==
| |
| | |
| ==Treatment==
| |
| ===NCEP recommendations for children and adolescents with high-risk hyperlipidemia===
| |
| | |
| [[Hyperlipidemia NCEP recommendations for drug therapy of high-risk hyperlipidemia in children and adolescents | Recommendations for drug therapy]] | [[Hyperlipidemia statins in children and adolescents with hyperlipidemia | Statins]] | [[Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents | Adjuvant therapies]]
| |
| | |
| ===[[Hypertriglyceridemia medical therapy | Pharmacotherapy]]===
| |
| | |
| [[Statins]] | [[Niacin]] | [[Fibrate]] | [[Omega-3 fatty acids]]===
| |
| | |
| ===Trial supportive data===
| |
| ====[[Niacin]]====
| |
| | |
| =====[[AIM HIGH study | Niacin AIM HIGH study]]=====
| |
| | |
| ==References==
| |
| {{reflist}}
| |
| | |
| ==External links==
| |
| * [http://profiles.nlm.nih.gov/FF/Views/Exhibit/visuals/scientist.html The Fredrickson papers (with photos from early lipoprotein research)]
| |
| * {{GPnotebook|745209914}}
| |
| <!-- previously these good links (OMIM normally inserted into the Template:Infobox Disease, but here there are separate ones for each Type. Rearranged into a table to try and compact down. -->
| |
| {| border=1 cellpadding=6 style="text-align:left"
| |
| |-
| |
| ! Hyperlipoproteinemia
| |
| ! OMIM
| |
| ! GPnotebook
| |
| ! WebMD
| |
| ! Others
| |
| |-
| |
| ! Type I
| |
| | {{OMIM|238600}}
| |
| | {{GPnotebook|-1389035478}}
| |
| | .
| |
| | [http://www.meritcare.com/hwdb/showTopic.asp?pd_hwid=nord474 MeritCare]
| |
| |-
| |
| ! Type IIa
| |
| | rowspan=2 | {{OMIM|144400}}
| |
| | {{GPnotebook|-1664090094}}
| |
| | .
| |
| | rowspan=2 | [http://www.merck.com/mrkshared/mmanual/section2/chapter15/15c.jsp Merck]
| |
| |-
| |
| ! Type IIb
| |
| <!-- OMIM for TypeII
| |
| -->| {{GPnotebook|-1375338454}}
| |
| | .
| |
| <!-- OMIM for TypeII
| |
| -->|-
| |
| ! Type III
| |
| | .
| |
| | {{GPnotebook|630849560}}
| |
| | [http://www.webmd.com/hw/health_guide_atoz/nord163.asp WebMD]
| |
| | [http://health.yahoo.com/ency/healthwise/nord163 Yahoo]
| |
| |-
| |
| ! Type IV
| |
| | {{OMIM|144600}}
| |
| | {{GPnotebook|-1362100182}}
| |
| | [http://aolsvc.health.webmd.aol.com/hw/cholesterol_management/nord624.asp WebMD]
| |
| | [http://health.yahoo.com/ency/healthwise/nord624 Yahoo]
| |
| |-
| |
| ! Type V
| |
| | {{OMIM|144600}}
| |
| | {{GPnotebook|-1355481046}}
| |
| | .
| |
| | .
| |
| |}
| |
| | |
| [[Category:Cardiology]]
| |
| [[Category:Lipid disorders]]
| |
| [[Category:Mature chapter]]
| |
| [[Category:Genetic disorders]]
| |
| [[Category:Metabolic disorders]]
| |
| | |
| [[de:Hyperlipoproteinämie]]
| |
| [[he:היפרליפידמיה]]
| |
| [[pt:Dislipidemia]]
| |
| [[ru:Гиперлипидемия]]
| |
| [[sv:Hyperlipidemi]]
| |
| | |
| {{WikiDoc Help Menu}}
| |
| {{WikiDoc Sources}}
| |